Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

QIAGEN

Qiagen is a provider of sample and assay technologies for molecular diagnostics and applied testing, including comple... read more Featured Products: More products

Download Mobile App




Diagnostic Biomarker Found for Esophageal Squamous Cell Carcinoma

By LabMedica International staff writers
Posted on 22 Jan 2020
Esophageal cancer is one of the most common malignant tumors in the world, and its incidence ranks seventh among those of all malignant tumors. More...
Esophageal cancer can be divided into two pathological types: squamous cell carcinoma (SCC) and adenocarcinoma.

Leucine‐rich repeat‐containing G protein–coupled receptor (LGR) plays a pivotal role in adult stem cells, which are markers of various types of adult stem cells in the skin, nails, and a group of basal and intraluminal progenitors that induce luminal tumorigenesis. LGR6 can promote the self‐renewal and progression of non–small‐cell lung cancer and has strong carcinogenic potential.

Scientists at the Fujian Medical University Union Hospital (Fuzhou, China) collected during surgical resection of esophageal cancer, 102 Esophageal Squamous Cell Carcinoma (ESCC) samples and their corresponding non‐tumor esophageal tissues. Tissues were immediately frozen in liquid nitrogen and stored in a −80 °C freezer or fixed in 10% formalin for paraffin embedding.

Total RNA was extracted from frozen tissue and 1 mg of RNA was reverse transcribed for first complementary DNA strand synthesis using a miScript Reverse Transcription Kit (Qiagen, Hilden Germany). Real‐time quantitative polymerase chain reaction (PCR) was performed using a SYBR Premix EX Taq Kit (TakaraBio, Shiga, Japan). The relative mRNA expression of LGR6 was detected with the 2(-Delta Delta C(T)) method using specific primers and its expression level was normalized to that of endogenous β‐actin. Other techniques used by the investigators included Western Blots Analysis and immunohistochemistry (IHC).

The scientists reported that the expression of LGR6 in ESCC tissues was significantly higher than that in normal tissues and was negatively correlated with the differentiation degree of ESCC and the prognosis of the patients but not closely correlated with the Classification of Malignant Tumors (TNM) stage of ESCC. Protein‐protein interaction (PPI) networks showed that LGR6 had a close interaction with R-spondin-1 (RSPO1), RSPO2, RSPO3, and RSPO4. Kyoto encyclopedia of genes and genomes (KEGG) pathway analysis showed that LGR6 activated the Wnt/β‐catenin signaling pathway by binding with RSPO ligands to promote the progression of ESCC.

The authors concluded that the study confirmed for the first time that LGR6 is highly expressed in ESCC tissues and that increased expression of LGR6 is associated with a poor prognosis of ESCC patients. These findings provide a basis for the potential application of LGR6 as a biomarker for early diagnosis and as a target gene for early therapeutic intervention. The study was published on January 9, 2020 in the Journal of Clinical Laboratory Analysis.

Related Links:
Fujian Medical University Union Hospital
Qiagen
TakaraBio



New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Collection and Transport System
PurSafe Plus®
New
Gold Member
Auto Hematology Analyzer
DH-88CS [H]
New
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.